Skip to Main Content

Paper Details

TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma.
Cancers (Basel)
7
2020
Author NameAffiliation
Zhengping ZhuangCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 1

Datasets

Release 1.2